Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05835063 · ClinicalTrials.gov registry record · NA

A Study to Improve Physician-Youth Communication and Medical Decision Making

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
62
Enrollment target

NCT05835063: Completed NA study, sponsored by University of Michigan.

NCT05835063 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05835063, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
62 participants
Enrollment target

Study Summary

The goal of this study is improving patient-centered communication for young people with advanced heart disease.

Primary Outcome

Satisfaction was based on the answers for 12 questions in which clinicians selected from a Likert scale from strongly disagree (1) -Strongly agree (5). The scores ranged from 12-60; higher scores indicated greater satisfaction.

Interventions

  • BEHAVIORAL We Chatt communication tool
  • BEHAVIORAL Usual/standard care

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2023-09-14
Est. Completion 2024-06-07
Phase NA
University of Michigan

1,327 total trials

What the finished NCT05835063 record still lists

NCT05835063 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which We Chatt communication tool is the first listed.

NCT05835063 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05835063 about?

NCT05835063 is a clinical study titled "A Study to Improve Physician-Youth Communication and Medical Decision Making". The goal of this study is improving patient-centered communication for young people with advanced heart disease.

What is the current status of trial NCT05835063?

This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2023-09-14. Estimated completion is 2024-06-07.

What interventions are being tested in trial NCT05835063?

The interventions under investigation include: We Chatt communication tool (BEHAVIORAL), Usual/standard care (BEHAVIORAL).

Who is sponsoring clinical trial NCT05835063?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05835063's enrollment target sits among peer trials

62 1157th of 2000 higher than 837 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03231150 · 62 participants · NA

    Plantar Fasciitis Randomized Clinical Control Trial

  • NCT03458676 · 62 participants · NA

    Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies

  • NCT03596086 · 62 participants · Phase 1

    HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

  • NCT03603405 · 62 participants · Phase 1

    HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05835063, the US trial registry maintained by the National Library of Medicine. NCT05835063 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.